Neuralstem Added To Russell 3000 Index Jun 30, 2014 09:15AM
Neuralstem's NSI-189 Novel Neurogenic Compound Shows Significant Effect In Major Depressive Disorder Jun 25, 2014 09:15AM
Neuralstem NSI-189 Select Data To Be Presented At Neuropsychopharmacology Congress Jun 19, 2014 09:15AM
Neuralstem Final Phase I Depression Data Presented At The American Society Of Clinical Psychopharmacology Annual Meeting Jun 18, 2014 09:15AM
Neuralstem Depression Trial Data to Be Presented at The American Society of Clinical Psychopharmacology Annual Meeting May 23, 2014 09:28AM


May 16, 2014 09:15AM Neuralstem CEO, Richard Garr, to Present at World Stem Cells & Regenerative Medicine Congress and Give Update on Trials
May 12, 2014 09:15AM Neuralstem Reports First Quarter Financial Results And Provides Business And Clinical Update
May 8, 2014 09:15AM Neuralstem Appoints Sandford Drexel Smith, Former Genzyme Executive Vice President, To Board Of Directors